Search results

The Powder Diffraction beamline at the Australian Synchrotron is optimised for carrying out structural investigation under non ambient conditions and as a function of time.

The Infrared Microspectroscopy beamline combines the high brilliance and collimation of the synchrotron beam through a Bruker V80v Fourier Transform Infrared (FTIR) spectrometer and into a Hyperion 3000 IR microscope to reach high signal-to-noise ratios at diffraction limited spatial resolutions between 3-8 μm.

The National Deuteration Facility offers the facilities and expertise to produce molecules where all or part of the molecular hydrogen is replaced with deuterium. This enables complex investigations of the relationship between the structure of molecules and their function using neutron scattering and other techniques.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.

Beamtime guide on the SAX / WAXS beamline at the Australian Synchrotron.

The THz/Far-IR Beamline couples the high brightness and collimation of a bend-magnet synchrotron radiation to a Bruker IFS125HR spectrometer providing high-resolution spectra (0.00096 cm-1) with signal to noise ratio superior to that of thermal sources up to 1350 cm-1 for gas-phase applications; the beamline also delivers signal to noise ratio superior to that of thermal sources up to 350 cm-1 for condensed phase samples.

The User Advisory Committee (UAC) is an independent group that provides advice to ANSTO Australian Synchrotron (AS) senior management on issues from a user perspective.

ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.

As a result of the successful optimisation testwork, Peak Resources has commissioned ANSTO Minerals to operate the pilot plant to validate the optimised “Alkali Roast” process flowsheet that has been selected by Peak for the Bankable Feasibility Study. The study is expected to be completed by early 2017.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.